Clinical cancer nanomedicine

J Wolfram, M Ferrari - Nano today, 2019 - Elsevier
Nanotechnology offers new solutions for the development of cancer therapeutics that display
improved efficacy and safety. Although several nanotherapeutics have received clinical …

Mechanisms of drug release in nanotherapeutic delivery systems

PT Wong, SK Choi - Chemical reviews, 2015 - ACS Publications
Targeted drug delivery refers to an established therapeutic strategy that develops platforms
and nanoscale devices for selective delivery of small drug molecules and therapeutic genes …

MMP-responsive 'smart'drug delivery and tumor targeting

Q Yao, L Kou, Y Tu, L Zhu - Trends in pharmacological sciences, 2018 - cell.com
Matrix metalloproteinases (MMPs) are major extracellular enzymes involved in cancer
initiation, progression, and metastasis. MMPs are widely used as cancer biomarkers and …

Polymer nanogels: a versatile nanoscopic drug delivery platform

RT Chacko, J Ventura, J Zhuang… - Advanced drug delivery …, 2012 - Elsevier
In this review we put the spotlight on crosslinked polymer nanogels, a promising platform
that has the characteristics of an “ideal” drug delivery vehicle. Some of the key aspects of …

Tumor microenvironment targeted nanotherapy

C Fernandes, D Suares, MC Yergeri - Frontiers in pharmacology, 2018 - frontiersin.org
Recent developments in nanotechnology have brought new approaches to cancer
diagnosis and therapy. While enhanced permeability and retention effect promotes nano …

Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery

E Gullotti, Y Yeo - Molecular pharmaceutics, 2009 - ACS Publications
One of the main goals of nanomedicine is to develop a nanocarrier that can selectively
deliver anticancer drugs to the targeted tumors. Extensive efforts have resulted in several …

Polysaccharide-based conjugates for biomedical applications

A Basu, KR Kunduru, E Abtew, AJ Domb - Bioconjugate chemistry, 2015 - ACS Publications
Polysaccharides contain different functional groups (such as hydroxyl, amino, carboxylic
acid, aldehydes) that make them ideal for conjugation. They are biodegradable …

A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis

SS Abolmaali, AM Tamaddon, R Dinarvand - Cancer chemotherapy and …, 2013 - Springer
Purpose Methotrexate (MTX) is one of the most widely studied and effective therapeutics
agents available to treat many solid tumors, hematologic malignancies, and autoimmune …

Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates

XX Zhang, HS Eden, X Chen - Journal of controlled release, 2012 - Elsevier
Peptides are attracting increasing attention as therapeutic agents, as the technologies for
peptide development and manufacture continue to mature. Concurrently, with booming …

[HTML][HTML] Protease-activated drug development

KY Choi, M Swierczewska, S Lee, X Chen - Theranostics, 2012 - ncbi.nlm.nih.gov
In this extensive review, we elucidate the importance of proteases and their role in drug
development in various diseases with an emphasis on cancer. First, key proteases are …